| Issue |
Section |
Title |
File |
| Vol 78, No 11 (2003) |
Editorial |
Development of approaches to enhancing adherence of patients withhuman immunodeficiency virus infection to antiretrovirustherapy |
|
| Vol 79, No 4 (2004) |
Editorial |
Antiretroviral therapy of acute HIV-infection |
|
| Vol 79, No 4 (2004) |
Editorial |
Secondary diseases in patients with HIV infection: 15-year follow-up |
|
| Vol 79, No 4 (2004) |
Editorial |
Characteristics of tuberculosis running with HIV-infection |
|
| Vol 79, No 11 (2004) |
Editorial |
Combined antiretroviral therapy with nevirapine of HIV-infected adults |
|
| Vol 81, No 4 (2009) |
Editorial |
Treatment of HIV infection in the Russian Federation |
|
| Vol 82, No 11 (2010) |
Editorial |
Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens |
|
| Vol 82, No 11 (2010) |
Editorial |
The course and treatment of chronic hepatitis B in HIV-infected patients |
|
| Vol 83, No 11 (2011) |
Editorial |
Diagnosis of tuberculous pericarditis in patients with HIV-infection |
|
| Vol 83, No 11 (2011) |
Editorial |
Current course of pneumocystic pneumonia in HIV-infected patients |
|
| Vol 83, No 11 (2011) |
Editorial |
Analysis of lethal outcomes in patients with newly-diagnosed tuberculosis of the respiratory organs in combination with HIV-infection |
|
| Vol 85, No 11 (2013) |
Editorial |
The value of changes in CD8+CD28+ and CD4+CD28+ cells in patients with HIV infection concurrent with tuberculosis during treatment |
|
| Vol 85, No 11 (2013) |
Editorial |
Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens |
|
| Vol 86, No 11 (2014) |
Editorial |
The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection |
|
| Vol 87, No 11 (2015) |
Editorial |
Impact of etiotropic therapy on the immune status of patients with HIV infection and tuberculosis |
|
